Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Politics : Sioux Nation -- Ignore unavailable to you. Want to Upgrade?

To: SiouxPal who wrote (103507)	3/30/2007 12:15:58 AM
From: stockman_scott	Read Replies (3) \| Respond to of 361235

Charlie Rose has some great interviews tonight... charlierose.com JESSICA MATHEWS President, The Carnegie Endowment for International Peace KANAN MAKIYA Professor, Brandeis University

To: SiouxPal who wrote (103507)	3/30/2007 12:46:21 AM
From: Patricia Trinchero	Read Replies (1) \| Respond to of 361235

This method of treatment can be risky in that the patient's blood gets sent to a company who then "tweaks" the white cells into killing off some cancer cells.................! Those cells are sent back to the patient and reinjected into him. God help the men that get their white cells mixed up in the lab. The best one can hope for is a few more months of survival and this treatment doesn't do anything to stop cancer growth. This is a far cry from a cure.